BRTX vs FAST · rev $401.0K vs P/E 43, rev $7.55B
BioRestorative Therapies Inc (BRTX) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
BRTX currently screens at market cap $10.2M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the BRTX and FAST stock pages for the full models.
Not investment advice.